Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now has funded $24,388,300 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 156 grants at over 100 hospitals in 29 countries.
Oncoceutics ONC201 - $83,333
$83,333.00
October 2018
Expansion of the ONC201 Compassionate Use.
The Institute of Cancer Research - $100,000
$100,000.00
October 2018
Short-pulse Ultrasound Delivery of Panobinostat for the Treatment of Diffuse Intrinsic Gliomas in Children
The Institute of Cancer Research - $106,647
$106,647.00
October 2018
A Mouse Model of HIST1H3B/ACVR1 Mutant DIPG.
Johns Hopkins Children's Center - $50,000
$50,000.00
July 2018
Using Zebrafish to Accelerate DIPG Drug Development.
Funding of PBTCF 2018: PBTC-058 - $16,800
$16,800.00
January 2018
PBTC-058: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma
The Campbell Family Institute for Cancer Research - $100,000
$100,000.00
October 2017
Defining the molecular mechanisms of DIPG development and progression to uncover novel therapeutic targets
Institute of Cancer Research - $102,432
$102,432.00
October 2017
Combinational strategies alongside ACVR1 inhibition in DIPG
The Regents of the University of California - $70,000
$70,000.00
October 2017
An Open Label Single Arm Phase I/II study of MTX110 delivered by convection-enhanced delivery (CED) in patients with diffuse intrinsic pontine glioma (DIPG) previously treated with external beam radiation therapy
The Hospital for Sick Children - $100,560
$100,560.00
October 2017
MRI Guided Focused Ultrasound: Towards Clinical Translation in Diffuse Intrinsic Pontine Glioma (DIPG)
Texas Children's Hospital and Ann & Robert H. Lurie Children's Hospital of Chicago - $200,000
$200,000.00
October 2017
Targeting DIPG through Combining a Super-activator (MCB-613) of Steroid Receptor Co-activators with Radiation.
Gustave Roussy - $101,868
$101,868.00
October 2017
Elucidating the underlying mechanisms of radio resistance at diagnosis and relapse in DIPG
Ospedale Pediatrico Bambino Gesu - $98,987
$98,987.00
October 2017
Investigating the role of DIPG-derived exosomes in tumor growth and invasion
Memorial Sloan Kettering Cancer Center - $100,000
$100,000.00
October 2017
Targeting EZH2 as a therapeutic strategy in DIPG
Dana-Farber Cancer Institute - $82,863
$82,863.00
October 2017
Defining the Cellular Architecture of Diffuse Intrinsic Pontine Glioma through Large-Scale Single-cell RNA-sequencing analyses
The Hospital of Sick Children - $162,828
$162,828.00
October 2017
Targeting DIPG through pharmacological activation of mitochondrial biogenesis: an in vitro and in vivo preclinical study